GlassScriptPhysician profile
Daniel J Yutronich
NPI 1881687788
$3,120.04
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,306 · 2020: $881 · 2021: $198 · 2022: $165 · 2023: $447 · 2024: $122.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $570.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $569.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $497.80 | 2019-2020 | |
| Novo Nordisk INC | $473.39 | 2019-2024 | Ozempic, Rybelsus |
| Abbvie INC. | $391.46 | 2021-2024 | Qulipta, Ubrelvy |
| Pfizer INC. | $286.10 | 2019-2023 | |
| Astellas Pharma US INC | $225.42 | 2019-2024 | Veozah, Myrbetriq |
| Boehringer Ingelheim Pharmaceuticals, INC. | $219.55 | 2019-2021 | |
| Lilly USA, LLC | $155.31 | 2019-2020 | |
| Amarin Pharma, INC. | $136.16 | 2019-2020 | |
| Glaxosmithkline, LLC. | $134.75 | 2019-2022 | |
| Amgen INC. | $132.46 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $79.61 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $77.20 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $38.56 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $38.09 | 2019-2020 | |
| Allergan, INC. | $37.75 | 2020 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $31.49 | 2019-2020 | |
| Sanofi Pasteur INC. | $27.78 | 2019 | |
| Genentech USA, INC. | $26.86 | 2019-2020 | |
| Abbott Laboratories | $22.96 | 2023 | Freestyle Libre |
| Merck Sharp & Dohme LLC | $22.69 | 2019-2020 | |
| Neurocrine Biosciences, INC. | $18.47 | 2020 | |
| Ironshore Pharmaceuticals INC. | $18.38 | 2019 | |
| Novartis Pharmaceuticals Corporation | $14.69 | 2019 | |
| Nestle Healthcare Nutrition INC. | $13.11 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Yutronich listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.